Search results for "bacteri"

showing 10 items of 5466 documents

Surface and virulence properties of environmental Vibrio cholerae non-O1 from Albufera Lake (Valencia, Spain).

1990

A total of 140 environmental Vibrio cholerae non-O1 isolates, together with several culture collection strains from both environmental and clinical sources, were studied in relation to hemagglutination, surface hydrophobicity, and the enzymatic, hemolytic, cytotoxic, and enterotoxic activities of their extracellular products. A total of 78 and 62% of the strains produced hemagglutinins and exohemagglutinins, respectively. Four different hemagglutinating and two exohemagglutinating activities were found by using eight sugars in the inhibition assays. Cell-bound mannose-sensitive hemagglutination was detected mainly in chicken blood, whereas fucose-sensitive hemagglutination was recorded only…

SerotypeHemagglutinationVirulenceFresh WaterEnterotoxinBiologymedicine.disease_causeApplied Microbiology and BiotechnologyMicrobiologyHemolysin ProteinsVibrio cholerae non-O1VibrionaceaemedicineVibrio choleraeAntigens BacterialEcologyVirulenceCytotoxinsO AntigensHemagglutininbiology.organism_classificationEnzymesHemagglutininsVibrio choleraeSpainWater MicrobiologyFood ScienceBiotechnologyPlasmidsResearch ArticleApplied and environmental microbiology
researchProduct

Characterization of Bacillus thuringiensis ser. balearica (Serotype H48) and ser. navarrensis (serotype H50): two novel serovars isolated in Spain.

2000

The novel strains of Bacillus thuringiensis PM9 and NA69, isolated from soil samples in Spain, were classified and characterized in terms of their crystal proteins, plasmid profile, cry genes content, and their toxicological properties against several species of Lepidoptera, Coleoptera, and Diptera. Both strains share morphological and biochemical characteristics with previously described B. thuringiensis strains, although their unique H antigens identify them as two new serotypes. Two new serovar names, B. thuringiensis serovar balearica (H serotype 48) and B. thuringiensis serovar navarrensis (H serotype 50) are proposed for the type strains PM9 and NA69, respectively.

SerotypeInsectaBacterial ToxinsImmunoblottingBacillus thuringiensisH antigenApplied Microbiology and BiotechnologyMicrobiologyPolymerase Chain ReactionMicrobiologyLepidoptera genitaliaHemolysin ProteinsPlasmidBacterial ProteinsBacillus thuringiensisAnimalsTypingSerotypingPest Control BiologicalSoil MicrobiologyInclusion BodiesAntigens BacterialBacillaceaebiologyBacillus thuringiensis ToxinsfungiGeneral Medicinebiology.organism_classificationBacillalesBacterial Typing TechniquesEndotoxinsElectrophoresis Polyacrylamide GelPlasmidsCurrent microbiology
researchProduct

Comparative study of biological properties and electrophoretic characteristics of lipopolysaccharide from eel-virulent and eel-A virulent Vibrio vuln…

1999

ABSTRACT In Vibrio vulnificus , virulence for eels is associated with serovar E strains. In this study, we investigated some biological properties of purified lipopolysaccharides (LPSs) from serovar E and non-serovar E strains. Purified LPSs retained their O-polysaccharidic side chains and did not show any differences that could be related to host specificity, except for serological differences.

SerotypeLipopolysaccharidesErythrocytesLipopolysaccharideVirulenceVibrio vulnificusApplied Microbiology and BiotechnologyHemolysisMicrobiologychemistry.chemical_compoundFish DiseasesMiceVibrionaceaeVibrio InfectionsAnimalsVibrioEelsEcologybiologyVirulenceO Antigensbiology.organism_classificationVibrioRatscarbohydrates (lipids)Environmental and Public Health MicrobiologychemistryVibrio Infectionslipids (amino acids peptides and proteins)BacteriaFood ScienceBiotechnologyApplied and environmental microbiology
researchProduct

Electrophoretic analysis of heterogeneous lipopolysaccharides from various strains of Vibrio vulnificus biotypes 1 and 2 by silver staining and immun…

1992

Lipopolysaccharides (LPS) of 11 strains of Vibrio vulnificus biotypes 1 and 2, isolated from an eel farm, and of 10 reference strains, were examined by SDS-polyacrylamide gel electrophoresis coupled with silver staining and immunoblotting. LPS samples were obtained from whole-cell lysates, outer membrane fragments, and extracellular products. By silver staining, only a diffuse band of low-molecular weight could be visualized in all cases except for a biotype 1 strain isolated from water. However, immunoblotting with antisera obtained against strains of biotypes 1 and 2 from eels allowed visualization of multiple O-polysaccharide chains. All biotype 2 strains, independently of their origins,…

SerotypeLipopolysaccharidesSilver StainingBlotting WesternVibrio vulnificusApplied Microbiology and BiotechnologyMicrobiologyMicrobiologySilver stainSpecies SpecificityVibrionaceaeAgglutination TestsAnimalsVibrioGel electrophoresisAntiserumEelsbiologyPolysaccharides BacterialO AntigensGeneral Medicinebiology.organism_classificationMolecular biologyAntibodies BacterialElectrophoresis Polyacrylamide GelRabbitsBacterial outer membraneBacteriaCurrent microbiology
researchProduct

Immunogenic antigens of the eel pathogen Vibrio vulnificus serovar E.

2003

Abstract The immunogenic antigens of Vibrio vulnificus serovar E were investigated in the eel. Fish were vaccinated by immersion with Vulnivaccine (V), revaccinated 2 years later by intraperitoneal injection (RV) and bath infected 15 days post-revaccination (RVI). The specific immune response in serum was followed in all groups, and selected sera were used for immunostaining of surface (SA) and extracellular antigens (ECA). Bacteria were grown in iron-rich (TSB and MSWYE) and iron-poor media (TSB and MSWYE plus human transferrin (TSB-T and MSWYE-T)) as well as eel serum (ES), and their SA and ECA were extracted and electrophoretically analysed. Cells grown in MSWYE-T and ES presented the sa…

SerotypeLipopolysaccharidesTime FactorsLipopolysaccharideIronImmunoblottingEnzyme-Linked Immunosorbent AssayVibrio vulnificusAquatic ScienceMicrobiologychemistry.chemical_compoundAntigenEnvironmental ChemistryAnimalsPathogenVibrio vulnificuschemistry.chemical_classificationAntigens BacterialbiologyImmune SeraGeneral Medicinebiology.organism_classificationAnguillachemistryTransferrinAntibody FormationBacterial VaccinesElectrophoresis Polyacrylamide GelBacterial outer membraneBacteriaBacterial Outer Membrane ProteinsFishshellfish immunology
researchProduct

First description of non-motile Yersinia ruckeri serovar I strains causing disease in rainbow trout, Oncorhynchus mykiss (Walbaum), cultured in Spain.

2006

Yersinia ruckeri, the causal agent of enteric redmouth (ERM) disease, was isolated from epizootics that occurred in different Spanish rainbow trout, Oncorhynchus mykiss (Walbaum), farms in which vaccination against ERM had been performed. In all episodes, the most pronounced clinical signs exhibited by affected fish were severe haemorrhages in the mouth, eyes and around the vent. The isolates were identified as Y. ruckeri serovar I by 16S rRNA sequencing together with serological tests. They lacked motility and lipase activity and thus belonged to biotype 2, and were highly virulent for juvenile rainbow trout, both by intraperitoneal injection (from 3.1 x 10(2) to 6.3 x 10(3) cfu per fish) …

SerotypeLipopolysaccharidesYersinia InfectionsVeterinary (miscellaneous)FisheriesVirulenceAquatic ScienceCommunicable Diseases EmergingPolymerase Chain ReactionMicrobiologyFish DiseasesAquacultureAgglutination TestsRNA Ribosomal 16SAnimalsSerologic TestsPathogenDNA PrimersbiologyVirulencebusiness.industryEnteric redmouth diseaseO Antigensbiology.organism_classificationAntibodies BacterialYersiniaTroutSpainOncorhynchus mykissRainbow troutYersinia ruckeribusinessJournal of fish diseases
researchProduct

Plasmid-Mediated Resistance to Antimicrobial Agents among Listeriae

1998

The resistance to 14 antiseptic-disinfectant and dye compounds of 208 strains of Listeria (132 L. monocytogenes, 63 L. innocua, 8 L. seeligeri, 1 L. ivanovii, 1 L. welshimeri, and 3 Listeria spp.) was tested by the agar-dilution procedure. The Listeria strains were isolated from different varieties of foods, environments of cheese dairies, humans, and wild birds. A total of 14 (6.7%) Listeria strains (12 L. monocytogenes and 2 L. innocua) were resistant to benzalkonium chloride, hexamidine diisethionate, and ethidium bromide. This multiple resistance was observed more frequently from strains of Listeria spp. detected on carcasses of poultry (47%) than strains isolated from human listeriosis…

SerotypeListeriaMicrobial Sensitivity TestsDrug resistancemedicine.disease_causeMicrobiologyMicrobiologyBirdsmedicineAnimalsHumansFood microbiologyListeriosisSerotypingColoring AgentsBacteriophage TypingPhage typingbiologyDrug Resistance MicrobialPlasmid-mediated resistancebiology.organism_classificationDrug Resistance MultipleAnti-Bacterial AgentsStaphylococcus aureusConjugation GeneticFood MicrobiologyListeriaBacteriaCadmiumPlasmidsFood ScienceJournal of Food Protection
researchProduct

Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vacc…

2010

13-valent pneumococcal conjugate vaccine (PCV13) was compared to PCV7 in infants administered 4 doses. For the 7 common serotypes, PCV13- and PCV7-elicited responses showed comparable percent responders achieving 0.35mug/mL IgG threshold (exception 6B, 77.5% versus 87.1%, respectively) and OPA titers of 1:8; IgGs were lower than PCV7 but functional responses were generally comparable. For the 6 additional serotypes, PCV13-elicited IgG and functional OPA responses were notably greater than PCV7. The toddler dose boosted immune responses. Vaccines were comparable with regard to safety. PCV13 should be as effective as PCV7 in preventing pneumococcal disease caused by the common serotypes and m…

SerotypeMaleHeptavalent Pneumococcal Conjugate Vaccinemedicine.disease_causecomplex mixturesPneumococcal conjugate vaccinePneumococcal InfectionsPneumococcal Vaccinesstomatognathic systemDouble-Blind MethodGermanyStreptococcus pneumoniaemedicineHeptavalent Pneumococcal Conjugate VaccineHumansImmunization ScheduleVaccines ConjugateGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryImmunogenicityPublic Health Environmental and Occupational HealthInfantmedicine.diseaseAntibodies BacterialVaccinationPneumococcal infectionsInfectious DiseasesImmunizationImmunoglobulin GImmunologyMolecular MedicineFemalebusinessmedicine.drugVaccine
researchProduct

Typhoid fever as a cause of opportunistic infection: case report.

2005

Abstract Background Typhoid fever is a systemic infection caused by the bacterium Salmonella enterica subspecies enterica serotype typhi, which is acquired by ingestion of contaminated food and water. Each year the disease affects at least 16 million persons world-wide, most of whom reside in the developing countries of Southeast Asia and Africa. In Italy the disease is uncommon with a greater number of cases in Southern regions than in Northern ones. Case presentation We report on a 57-year-old Sri-Lankan male affected by typhoid fever, the onset of which was accompanied by oropharyngeal candidiasis. This clinical sign was due to a transient cell-mediated immunity depression (CD4+ cell cou…

SerotypeMalemedicine.medical_specialtyOpportunistic infectionCase ReportDiseaseOpportunistic InfectionsTyphoid feverlcsh:Infectious and parasitic diseasesMicrobiologythiphoidMedical microbiologyAnti-Infective AgentsCandidiasis OralmedicineHumanslcsh:RC109-216Typhoid FeverSri Lankabiologybusiness.industryMiddle Agedbiology.organism_classificationmedicine.diseasebacterial infections and mycosesVirologyInfectious DiseasesParasitologySalmonella entericaTropical medicinebusinessBMC infectious diseases
researchProduct

Effectiveness of different vaccine formulations against vibriosis caused by Vibrio vulnificus serovar E (biotype 2) in European eels Anguilla anguilla

2001

Vibriosis due to Vibrio vulnificus serovar E (biotype 2) is one of the main causes of mortality in European eels cultured in Europe. The main objective of this study was to develop a vaccine and a vaccination procedure against this pathogen. With this aim, we tested several vaccine formulations (inactivated whole-cells with and without toxoids‹inactivated extracellular products‹from capsulated and uncapsulated strains, attenuated live vaccines and purified lipopolysaccharide [LPS]) on eels maintained under controlled laboratory conditions using different delivery routes (injection and immersion). To study the immune response we estimated antibody titers and bactericidal/bacteriostatic activ…

SerotypeQuality ControlVibrio vulnificus serovar E ; Vibrio vulnificus biotype 2 ; Eel vaccines ; Vibrio vaccines ; Vaccination by injection ; Vaccination by prolonged immersionImmunization SecondaryVibrio vulnificus biotype 2Eel vaccinesVibrio vulnificusAquacultureAquatic ScienceBiologyAntibodies Viral:CIENCIAS DE LA VIDA [UNESCO]MicrobiologyFish DiseasesVaccination by injectionAntigenVibrionaceaeImmunityAntibody SpecificityUNESCO::CIENCIAS DE LA VIDAAnimalsUNESCO::CIENCIAS DE LA VIDA::Biología animal (Zoología)Vibrio vaccinesPathogenEcology Evolution Behavior and SystematicsVaccination by prolonged immersionSkinVibrio:CIENCIAS DE LA VIDA::Biología animal (Zoología) [UNESCO]VaccinationAntibody titerbiology.organism_classificationAnguillaVirologyVaccinationEuropeVibrio vulnificus serovar EVibrio InfectionsBacterial Vaccines
researchProduct